Goldman Sachs’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-94,275
Closed -$3.04M – 6925
2016
Q3
$3.04M Hold
94,275
– – ﹤0.01% 3463
2016
Q2
$2.91M Buy
+94,275
New +$2.95M ﹤0.01% 3295
2014
Q2
– Sell
-32,305
Closed -$923K – 7015
2014
Q1
$923K Buy
+32,305
New +$841K ﹤0.01% 4751

Other funds holding EHC

Goldman Sachs's EHC Position: Q2 2026 in Review

Goldman Sachs reduced its Encompass Health (EHC) stake by 14% in Q2 2026, selling an estimated $26.4M and leaving 1,550,797 shares worth $157M. The position accounts for 0.01% of the portfolio, ranked #906.

Goldman Sachs first reported a position in EHC in Q2 2013 and has held it in 53 quarters since. The position peaked at $175M in Q1 2026. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Goldman Sachs held 1,550,797 shares of Encompass Health worth $157M as of Q2 2026.
  • Goldman Sachs sold 254,924 Encompass Health shares in Q2 2026, an estimated $26.4M.
  • Encompass Health made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #906 holding.
  • Goldman Sachs first reported a position in Encompass Health in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Encompass Health position peaked at $175M in Q1 2026.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.